International
Jan. 28, 2011
New Partnership Could Open China to U.S. Biotechs
U.S. pharmaceutical and medical device companies could gain greater access to the world's most populous nation through a new collaboration between the United States and China, but it's too early to say how the joint initiative will address the biotechnology industry's ongoing regulatory and intellectual property concerns.
Daily Journal Staff Writer
U.S. pharmaceutical and medical device companies could gain greater access to the world's most populous nation through a new collaboration between the U.S. and China, but it's too early to say how the joint initiative would address the biotechnology industry's ongoing regulatory and intellectual property concerns.
Under the public-private partnership on health care announced during Chines...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In